Senior Vice President, CEO Loxo Oncology at Lilly and President, Lilly Oncology · ELI LILLY & Co (LLY)

Jacob Van Naarden

FY2021 is the first fiscal year CompBrief holds for Jacob Van Naarden as a named executive officer of ELI LILLY; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$6,122,742

Salary $745,649Stock awards $4,099,500Bonus $218,715

3rd of 7 named executive officers at ELI Lilly by FY2021 total.

7 named officers on file for ELI LILLY, FY2021

Jacob Van Naarden’s pay file — $29

  • 1 fiscal year of pay, line by line
  • LLY’s disclosed peer group of 35 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ELI LILLY’s whole pay program stands against its peers

  • ELI LILLY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LLY→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 18, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jacob Van Naarden’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jacob Van Naarden compensation by year

ELI LILLY Summary Compensation Table · the one fiscal year held
In US dollars, as ELI LILLY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$745,649
Bonus$218,715
Stock awards$4,099,500
Option awards$0
Non-equity incentive$1,029,507
Pension and deferred compensation$16,909
All other$12,462
Total$6,122,742

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ELI LILLY & Co DEF 14A filed March 18, 2022, accession 0000059478-22-000099, and prior-year filings.

How this page was built: the ELI LILLY & Co filed document, accession 0000059478-22-000099. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2022.

Insider transactions since the last proxy

10 Form 4 lines since the FY2021 proxy (filed March 18, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-09Grant or award—4,865.89$1044.6726,626.5
2026-02-01Tax withholding—1,909.38$1037.1522,760.61
2026-02-01Exercise or conversion derivative—4,108$0.000
2026-02-01Exercise or conversion—4,108$0.0024,669.99
2025-08-13Purchase—1,000$647.3620,561.99
2025-02-10Grant or award derivative—4,108$0.004,108
2025-02-10Grant or award—6,103.82$868.8819,561.99
2025-02-01Exercise or conversion derivative—3,023$0.000

The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ELI LILLY’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David RicksChair, President, and CEO$21,509,985
Daniel SkovronskySenior Vice President, Chief Scientific and Medical Officer and President, Lilly Research Laboratories$7,527,092
Jacob Van Naarden · this pageSenior Vice President, CEO Loxo Oncology at Lilly and President, Lilly Oncology$6,122,742
Diogo RauSenior Vice President and Chief Information and Digital Officer$5,101,328
Anat AshkenaziSenior Vice President and Chief Financial Officer$4,657,609
Anat HakimExecutive Vice President, General Counsel and Secretary$4,017,853
Joshua SmileyFormer Senior Vice President and Chief Financial Officer$244,681

The full ELI LILLY compensation record

free company brief

This page is one person within ELI LILLY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ELI LILLY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ELI LILLY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jacob Van Naarden's compensation dossier · One-time report. No refunds.